dc.contributor.author | Ballard, Clive | |
dc.date.accessioned | 2020-10-06T14:32:22Z | |
dc.date.available | 2020-10-06T14:32:22Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | Ballard C, Corbett A. Commentary: Opportunities for Combination Trials. J Prev Alzheimers Dis. 2019;6(3):177-178. doi: 10.14283/jpad.2019.17. | en_US |
dc.identifier.pmid | 31062829 | |
dc.identifier.doi | 10.14283/jpad.2019.17 | |
dc.identifier.uri | https://rde.dspace-express.com/handle/11287/621458 | |
dc.language.iso | en | en_US |
dc.publisher | Springer | en_US |
dc.relation.url | https://doi.org/10.14283/jpad.2019.17 | en_US |
dc.rights | Copyright © 2012 - The Journal of Prevention of Alzheimer's Disease | en_US |
dc.subject | Advisory Committees | en_US |
dc.subject | Alzheimer Disease | en_US |
dc.subject | Combined Modality Therapy | en_US |
dc.title | Commentary: Opportunities for Combination Trials | en_US |
dc.type | Comment | en_US |
dc.identifier.journal | The Journal of Prevention of Alzheimer's Disease | en_US |
dc.type.version | Published | en_US |